As part of our new special feature, we look at some of the latest technologies, resources, and techniques advancing drug discovery. Discover how T cell activation assays are helping to identify vaccine epitopes for COVID-19, explore how binding kinetics of unknown compounds can be determined by TR-FRET-based kinetic probe competition assays, find out how to increase reproducibility and walk-away time with ELISA automation, and much more.
Learn about the role of T cell activation assays in conﬁrming the immunity of COVID-19 patients and determining top epitope candidates for vaccine development.
Discover a TR-FRET-based kinetic probe competition assay (kPCA) for the determination of binding kinetics of unlabeled compounds in high throughput.
Download a step-by-step procedure for performing a fully automated sandwich ELISA using the ASSIST PLUS pipetting robot.
Find out more about the future trends in biopharmaceutical development, including multi-attribute monitoring, biophysical analysis as a complement to analytical characterization, and the rise of mass detection.
Discover a multiplexed, automated method to assess cytotoxicity using Analytik Jena's CyBio® FeliX liquid handling system. Learn how the method ensures consistent experimental setup and enhances efficiency.
Learn why Thermo Scientific™ Nunc™ Immunoassay Plates make an ideal tool for SARS-CoV-2 assay development and production, through their immobilization of glycoproteins and proteins.
Fluidic Analytics describes the application of microfluidic diffusional sizing to accurately measure the affinity of an anti-spike S1 antibody to fluorescently labeled SARS-CoV-2 RBD directly in serum.
BellBrook Labs presents strategies for hit-to-lead selection, including assay considerations, running a dose-response, hit confirmation, triaging, hit expansion, mechanism of action, and residence time studies.
In this SelectScience interview, Lori Euler, Pall Laboratory, shares how collaboration between Pall and key life sciences researchers is helping to innovate and accelerate biologic development.
Take a look at what other researchers and scientists all over the world are saying about the latest equipment and technologies in drug discovery. Houda Montacir, from Alvotech, shared his opinion on the BioAccord LC-MS System by Waters.